DSM Biologics and Crucell Announce PER.C6 Licensing Agreement with Biotecnol SA for Antibody Production
09-Jan-2007 -
DSM Biologics, a business unit of DSM Pharmaceutical Products and Crucell N.V. announced that they have signed a PER.C6® license agreement with Portuguese biotechnology company, Biotecnol SA, and its USA based subsidiary Biotecnol, Inc. This license agreement allows Biotecnol to use the PER.C6® ...
antibodies
biotechnology
cell lines
+3